[1]
|
Smith, M.H. and Berman, J.R. (2022) What Is Rheumatoid Arthritis? JAMA, 327, 1194-1194.
https://doi.org/10.1001/jama.2022.0786
|
[2]
|
Radu, A.F. and Bungau, S.G. (2021) Management of Rheumatoid Arthritis: An Overview. Cells, 10, Article No. 2857.
https://doi.org/10.3390/cells10112857
|
[3]
|
Aviña-Zubieta, J.A., Choi, H.K., Sadatsafavi, M., Etminan, M., Esdaile, J.M. and Lacaille, D. (2008) Risk of Cardiovascular Mortality in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies. Arthritis & Rheumatology, 59, 1690-1697. https://doi.org/10.1002/art.24092
|
[4]
|
Kadura, S. and Raghu, G. (2021) Rheumatoid Arthritis-Interstitial Lung Disease: Manifestations and Current Concepts in Pathogen-esis and Management. European Respiratory Review, 30, Article ID: 210011.
https://doi.org/10.1183/16000617.0011-2021
|
[5]
|
Finckh, A., Gilbert, B., Hodkinson, B., Bae, S.C., Thomas, R., Deane, K.D., Alpizar-Rodriguez, D. and Lauper, K. (2022) Global Epidemiology of Rheumatoid Arthritis. Nature Re-views Rheumatology, 18, 591-602.
https://doi.org/10.1038/s41584-022-00827-y
|
[6]
|
Kawai, V.K., Shi, M., Feng, Q., Chung, C.P., Liu, G., Cox, N.J., et al. (2020) Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-Analysis. Arthritis & Rheumatology, 72, 1483-1492. https://doi.org/10.1002/art.41291
|
[7]
|
Maeda, K., Yoshida, K., Nishizawa, T., Otani, K., Yamashita, Y., Okabe, H., et al. (2022) Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. International Journal of Molecular Sciences, 23, Article No. 2871. https://doi.org/10.3390/ijms23052871
|
[8]
|
Kondo, N., Kuroda, T. and Kobayashi, D. (2021) Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis. International Journal of Molecular Sciences, 22, Article No. 10922. https://doi.org/10.3390/ijms222010922
|
[9]
|
Lopez-Castejon, G. and Brough, D. (2011) Understanding the Mecha-nism of IL-1β Secretion. Cytokine and Growth Factor Reviews, 22, 189-195. https://doi.org/10.1016/j.cytogfr.2011.10.001
|
[10]
|
Pein, M., Insua-Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., et al. (2020) Metastasis-Initiating Cells Induce and Exploit a Fibroblast Niche to Fuel Malignant Coloni-zation of the Lungs. Nature Communications, 11, Article No. 1494. https://doi.org/10.1038/s41467-020-15188-x
|
[11]
|
Arima, Y., Kamimura, D., Atsumi, T., Harada, M., Kawamoto, T., Nishikawa, N., Stofkova, A., et al. (2015) A Pain- Mediated Neural Signal Induces Relapse in Murine Autoimmune Encephalomyelitis, a Multiple Sclerosis Model. Elife, 4, e08733. https://doi.org/10.7554/eLife.08733
|
[12]
|
Mailhot, B., Christin, M., Tessandier, N., Sotoudeh, C., Bretheau, F., Turmel, R., et al. (2020) Neuronal Interleukin-1 Receptors Mediate Pain in Chronic Inflammatory Diseases. Journal of Experimental Medicine, 217, e20191430.
https://doi.org/10.1084/jem.20191430
|
[13]
|
Karpouzas, G.A., Ormseth, S.R., Hernandez, E. and Budoff, M.J. (2020) Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions. Arthritis & Rheumatology, 72, 1467-1475. https://doi.org/10.1002/art.41293
|
[14]
|
Boyapati, A., Schwartzman, S., Msihid, J., Choy, E., Genovese, M.C., Burmester, G.R., et al. (2020) Association of High Serum Interleukin-6 Levels with Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab from Adalimumab or Methotrexate in a Post Hoc Analysis. Arthritis & Rheumatology, 72, 1456-1466. https://doi.org/10.1002/art.41299
|
[15]
|
Bell, R.D., Rahimi, H., Kenney, H.M., Lieberman, A.A., Wood, R.W., Schwarz, E.M. and Ritchlin, C.T. (2020) Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients with Active Rheumatoid Arthritis. Arthritis & Rheumatology, 72, 1447-1455. https://doi.org/10.1002/art.41311
|
[16]
|
Atzeni, F., Nucera, V., Masala, I.F., Sarzi-Puttini, P. and Bonitta, G. (2019) Il-6 Involvement in Pain, Fatigue and Mood Disorders in Rheumatoid Ar-thritis and the Effects of Il-6 Inhibitor Sarilumab. Pharmacological Research, 149, Article ID: 104402. https://doi.org/10.1016/j.phrs.2019.104402
|
[17]
|
Brenn, D., Richter, F. and Schaible, H.G. (2007) Sensitization of Unmyelinated Sensory Fibers of the Joint Nerve to Mechanical Stimuli by Interleukin-6 in the Rat: An Inflammatory Mechanism of Joint Pain. Arthritis & Rheumatology, 56, 351-359. https://doi.org/10.1002/art.22282
|
[18]
|
Zhou, Y.Q., Liu, Z., Liu, Z.H., Chen, S.P., Li, M., Shahveranov, A., Ye, D.W. and Tian, Y.K. (2016) Interleukin-6: An Emerging Regulator of Pathological Pain. Journal of Neuroinflammation, 13, Article No. 141.
https://doi.org/10.1186/s12974-016-0607-6
|
[19]
|
Onuora, S. (2022) Calprotectin Tracks Tocilizumab-Treated RA. Nature Reviews Rheumatology, 18, Article No. 612.
https://doi.org/10.1038/s41584-022-00851-y
|
[20]
|
Giles, J.T., Sattar, N., Gabriel, S., Ridker, P.M., Gay, S., Warne, C., et al. (2020) Cardiovascular Safety of Tocilizumab versus Etanercept in Rheumatoid Arthritis: A Randomized Con-trolled Trial. Arthritis & Rheumatology, 72, 31-40.
https://doi.org/10.1002/art.41095
|
[21]
|
Yi, X.M., Li, M., Chen, Y.D., Shu, H.B. and Li, S. (2022) Reciprocal Reg-ulation of IL-33 Receptor-Mediated Inflammatory Response and Pulmonary Fibrosis by TRAF6 and USP38. Proceed-ings of the National Academy of Sciences of the United States of America, 119, e2116279119. https://doi.org/10.1073/pnas.2116279119
|
[22]
|
Yuan, C. (2022) IL-33 in Autoimmunity, Possible Therapeutic Tar-get. International Immunopharmacology, 108, Article ID: 108887. https://doi.org/10.1016/j.intimp.2022.108887
|
[23]
|
Wu, S., Jiang, Y., Teng, Y., Liu, X., Zhou, L. and Li, W. (2021) Interleukin-33 Promotes Proliferation and Inhibits Apoptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Clinical and Experimental Rheumatology, 39, 844- 851. https://doi.org/10.55563/clinexprheumatol/htpmp0
|
[24]
|
Iwaszko, M., Wielińska, J., Świerkot, J., Kolossa, K., Sokolik, R., Bugaj, B., et al. (2021) IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients. Frontiers in Immunology, 12, Article ID: 631603.
https://doi.org/10.3389/fimmu.2021.631603
|
[25]
|
Ruiz de Morales, J.M.G., Puig, L., Daudén, E., Cañete, J.D., Pablos, J.L., Martín, A.O., et al. (2020) Critical Role of Interleukin (IL)-17 in Inflammatory and Immune Disorders: An Updated Review of the Evidence Focusing in Controversies. Autoimmunity Reviews, 19, Article ID: 102429. https://doi.org/10.1016/j.autrev.2019.102429
|
[26]
|
Du, J., Zheng, L., Chen, S., Wang, N., Pu, X., Yu, D., et al. (2022) NFIL3 and Its Immunoregulatory Role in Rheumatoid Arthritis Patients. Frontiers in Immunology, 13, Article ID: 950144. https://doi.org/10.3389/fimmu.2022.950144
|
[27]
|
Adib, M., Taghadosi, M., Tahmasebi, M.N., Sharafat Vaziri, A., Jamshidi, A., Mahmoudi, M. and Farhadi, E. (2023) Anti-Inflammatory Effects of PRIMA-1MET (Mutant p53 Reactivator) Induced by Inhibition of Nuclear Factor-κB on Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Inflam-mopharmacology, 31, 385-394.
https://doi.org/10.1007/s10787-022-01094-9
|
[28]
|
Taams, L.S. (2020) Interleukin-17 in Rheumatoid Arthritis: Tri-als and Tribulations. Journal of Experimental Medicine, 217, e20192048. https://doi.org/10.1084/jem.20192048
|
[29]
|
Chen, Z., Fan, R., Liang, J., Xiao, Z., Dang, J., Zhao, J., et al. (2022) NFIL3 Deficiency Alleviates EAE through Regulating Different Immune Cell Subsets. Journal of Advanced Research, 39, 225-235.
https://doi.org/10.1016/j.jare.2021.10.011
|
[30]
|
Yang, W., Li, J., Zhang, M., Yu, H., Zhuang, Y., Zhao, L., et al. (2022) Elevated Expression of the Rhythm Gene NFIL3 Promotes the Progression of TNBC by Activating NF-κB Sig-naling through Suppression of NFKBIA Transcription. Journal of Experimental & Clinical Cancer Research, 41, Article No. 67.
https://doi.org/10.1186/s13046-022-02260-1
|
[31]
|
Sorokin, A.V. and Mehta, N.N. (2022) The Relationship be-tween TNF-Alpha Driven Inflammation, Lipids, and Endothelial Function in Rheumatoid Arthritis: A Complex Puzzle Continues. Cardiovascular Research, 118, 10-12.
https://doi.org/10.1093/cvr/cvab190
|
[32]
|
Akram, M., Daniyal, M., Sultana, S., Owais, A., Akhtar, N., Zahid, R., et al. (2021) Traditional and Modern Management Strategies for Rheumatoid Arthritis. Clinica Chimica Acta, 512, 142-155.
https://doi.org/10.1016/j.cca.2020.11.003
|
[33]
|
Noda, K., Tajima, M., Oto, Y., Saitou, M., Yoshiga, M., Otani, K., Yoshida, K. and Kurosaka, D. (2020) How Do Neuropathic Pain-Like Symptoms Affect Health-Related Quality of Life among Patients with Rheumatoid Arthritis? A Comparison of Multiple Pain-Related Parameters. Modern Rheumatology, 30, 828-834.
https://doi.org/10.1080/14397595.2019.1650462
|
[34]
|
Yokota, K., Sato, K., Miyazaki, T., Aizaki, Y., Tanaka, S., Sekikawa, M., et al. (2021) Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteo-clasts in Rheumatoid Arthritis. Arthritis & Rheumatology, 73, 1145-1154. https://doi.org/10.1002/art.41666
|
[35]
|
Siegel, R.J., Singh, A.K., Panipinto, P.M., Shaikh, F.S., Vinh, J., Han, S.U., et al. (2022) Extracellular Sulfatase-2 Is Overexpressed in Rheumatoid Arthritis and Mediates the TNF-α-Induced In-flammatory Activation of Synovial Fibroblasts. Cellular & Molecular Immunology, 19, 1185-1195. https://doi.org/10.1038/s41423-022-00913-x
|
[36]
|
Chaabo, K. and Kirkham, B. (2015) Rheumatoid Arthri-tis—Anti-TNF. International Immunopharmacology, 27, 180-184.
https://doi.org/10.1016/j.intimp.2015.04.051
|
[37]
|
Lauper, K., Iudici, M., Mongin, D., Bergstra, S.A., Choquette, D., Codreanu, C., et al. (2022) Effectiveness of TNF- Inhibitors, Abatacept, IL6-Inhibitors and JAK-Inhibitors in 31 846 Pa-tients with Rheumatoid Arthritis in 19 Registers from the “JAK-Pot” Collaboration. Annals of the Rheumatic Diseases, 81, 1358-1366.
https://doi.org/10.1136/annrheumdis-2022-222586
|
[38]
|
Kalden, J.R. and Schulze-Koops, H. (2017) Immunogenic-ity and Loss of Response to TNF Inhibitors: Implications for Rheumatoid Arthritis Treatment. Nature Reviews Rheuma-tology, 13, 707-718.
https://doi.org/10.1038/nrrheum.2017.187
|
[39]
|
Zufferey, P., Perreau, M. and So, A. (2015) High Level of An-ti-Drug Antibodies after Intra-Articular Injection of Anti-TNF. Rheumatology (Oxford), 54, 2291-2292. https://doi.org/10.1093/rheumatology/kev325
|
[40]
|
de Almeida, L.G.N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L. and Dufour, A. (2022) Matrix Metalloproteinases: From Molecular Mechanisms to Physi-ology, Pathophysiology, and Pharmacology. Pharmacological Reviews, 74, 712-768. https://doi.org/10.1124/pharmrev.121.000349
|
[41]
|
Alamgeer, Hasan, U.H., Uttra, A.M., Qasim, S., Ikram, J., Saleem, M. and Niazi, Z.R. (2020) Phytochemicals Targeting Matrix Metalloproteinases Regulating Tissue Degradation in Inflammation and Rheumatoid Arthritis. Phytomedicine, 66, Article ID: 153134. https://doi.org/10.1016/j.phymed.2019.153134
|
[42]
|
Laronha, H. and Caldeira, J. (2020) Structure and Function of Human Matrix Metalloproteinases. Cells, 9, Article No. 1076. https://doi.org/10.3390/cells9051076
|
[43]
|
Mehana, E.E., Khafaga, A.F. and El-Blehi, S.S. (2019) The Role of Matrix Metalloproteinases in Osteoarthritis Pathogenesis: An Updated Review. Life Sciences, 234, Article ID: 116786. https://doi.org/10.1016/j.lfs.2019.116786
|
[44]
|
Zhang, H., Cai, D. and Bai, X. (2020) Macrophages Regulate the Progression of Osteoarthritis. Osteoarthritis Cartilage, 28, 555-561. https://doi.org/10.1016/j.joca.2020.01.007
|
[45]
|
Mahmoud, R.K., El-Ansary, A.K., El-Eishi, H.H., Kamal, H.M. and El-Saeed, N.H. (2005) Matrix Metalloproteinases MMP-3 and MMP-1 Levels in Sera and Synovial Fluids in Patients with Rheumatoid Arthritis and Osteoarthritis. Italian Journal of Biochemistry, 54, 248-257.
|
[46]
|
Hu, Q. and Ecker, M. (2021) Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. International Journal of Molecular Sciences, 22, Article No. 1742. https://doi.org/10.3390/ijms22041742
|
[47]
|
Malemud, C.J. (2017) Matrix Metalloproteinases and Synovial Joint Pathology. Progress in Molecular Biology and Trans- lational Science, 148, 305-325. https://doi.org/10.1016/bs.pmbts.2017.03.003
|
[48]
|
Liu, H., Zhu, Y., Gao, Y., Qi, D., Zhao, L., Zhao, L., et al. (2020) NR1D1 Modulates Synovial Inflammation and Bone Destruction in Rheumatoid Arthritis. Cell Death & Disease, 11, Article No. 129.
https://doi.org/10.1038/s41419-020-2314-6
|
[49]
|
Yilmaz, D., Niskanen, K., Gonullu, E., Tervahartiala, T., Gürsoy, U.K. and Sorsa, T. (2023) Salivary and Serum Levels of Neutrophil Proteases in Periodontitis and Rheumatoid Arthritis. Oral Diseases. https://doi.org/10.1111/odi.14574
|
[50]
|
Raeeszadeh-Sarmazdeh, M., Do, L.D. and Hritz, B.G. (2020) Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Cells, 9, Article No. 1313. https://doi.org/10.3390/cells9051313
|
[51]
|
Zhang, Y., Liu, J., Wang, C., Liu, J. and Lu, W. (2021) Toll-Like Re-ceptors Gene Polymorphisms in Autoimmune Disease. Frontiers in Immunology, 12, Article ID: 672346. https://doi.org/10.3389/fimmu.2021.672346
|
[52]
|
Wang, Y.J., Zhong, X.Y., Wang, X.H., Zhong, Y.H., Liu, L., Liu, F.Y., et al. (2022) Activity of Codonopsiscanescens against Rheumatoid Arthritis Based on TLRs/MAPKs/NF-κB Sig-naling Pathways and Its Mechanism. China Journal of Chinese Materia Medica, 47, 6164-6174.
|
[53]
|
Lin, Y.J., Anzaghe, M. and Schülke, S. (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells, 9, Article No. 880. https://doi.org/10.3390/cells9040880
|
[54]
|
Arleevskaya, M.I., Larionova, R.V., Brooks, W.H., Bettacchioli, E. and Renaudineau, Y. (2020) Toll-Like Receptors, Infections, and Rheumatoid Arthritis. Clinical Reviews in Allergy & Immunology, 58, 172-181.
https://doi.org/10.1007/s12016-019-08742-z
|
[55]
|
Emami, J. and Ansarypour, Z. (2019) Receptor Targeting Drug Delivery Strategies and Prospects in the Treatment of Rheumatoid Arthritis. Research in Pharmaceutical Sciences, 14, 471-487. https://doi.org/10.4103/1735-5362.272534
|
[56]
|
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Oka-moto, M., Ishihara, A., Kayama, T., Saito, M. and Marumo, K. (2019) The Regulation of Bone Metabolism and Disor-ders by Wnt Signaling. International Journal of Molecular Sciences, 20, Article No. 5525. https://doi.org/10.3390/ijms20225525
|
[57]
|
Kobayashi, Y., Uehara, S., Udagawa, N. and Takahashi, N. (2016) Featured: Regulation of Bone Metabolism by Wnt Signals. Journal of Biochemistry, 159, 387-392. https://doi.org/10.1093/jb/mvv124
|
[58]
|
Weivoda, M.M., Ruan, M., Hachfeld, C.M., Pederson, L., Howe, A., Davey, R.A., et al. (2019) Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. Journal of Bone and Mineral Research, 34, 1546-1548. https://doi.org/10.1002/jbmr.3740
|
[59]
|
McLornan, D.P., Pope, J.E., Gotlib, J. and Harrison, C.N. (2021) Current and Future Status of JAK Inhibitors. The Lancet, 398, 803-816. https://doi.org/10.1016/S0140-6736(21)00438-4
|
[60]
|
Angelini, J., Talotta, R., Roncato, R., Fornasier, G., Barbiero, G., Dal Cin, L., Brancati, S. and Scaglione, F. (2020) JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future. Biomolecules, 10, Article No. 1002. https://doi.org/10.3390/biom10071002
|
[61]
|
Crispino, N. and Ciccia, F. (2021) JAK/STAT Pathway and Nocicep-tive Cytokine Signalling in Rheumatoid Arthritis and Psoriatic Arthritis. Clinical and Experimental Rheumatology, 39, 668-675.
https://doi.org/10.55563/clinexprheumatol/e7ayu8
|
[62]
|
McInnes, I.B. and Schett, G. (2017) Pathogenetic Insights from the Treatment of Rheumatoid Arthritis. The Lancet, 389, 2328-2337. https://doi.org/10.1016/S0140-6736(17)31472-1
|
[63]
|
Simon, L.S., Taylor, P.C., Choy, E.H., Sebba, A., Quebe, A., Knopp, K.L. and Porreca, F. (2021) The Jak/STAT Pathway: A Focus on Pain in Rheumatoid Arthritis. Seminars in Ar-thritis and Rheumatism, 51, 278-284.
https://doi.org/10.1016/j.semarthrit.2020.10.008
|
[64]
|
Cunningham, C.C., Wade, S., Floudas, A., Orr, C., McGarry, T., Wade, S., et al. (2021) Serum miRNA Signature in Rheu- matoid Arthritis and “At-Risk Individuals”. Frontiers in Immunology, 12, Article ID: 633201.
https://doi.org/10.3389/fimmu.2021.633201
|
[65]
|
Saliminejad, K., Khorram Khorshid, H.R., Soleymani Fard, S. and Ghaffari, S.H. (2019) An Overview of microRNAs: Biology, Functions, Therapeutics, and Analysis Methods. Journal of Cellular Physiology, 234, 5451-5465.
https://doi.org/10.1002/jcp.27486
|
[66]
|
Green, D., Dalmay, T. and Chapman, T. (2016) Microguards and Mi-cromessengers of the Genome. Heredity (Edinb), 116, 125-134. https://doi.org/10.1038/hdy.2015.84
|
[67]
|
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008) Characterization of microRNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases. Cell Research, 18, 997-1006.
https://doi.org/10.1038/cr.2008.282
|
[68]
|
Reyes-Long, S., Cortes-Altamirano, J.L., Clavijio-Cornejo, D., Gutiérrez, M., Bertolazzi, C., Bandala, C., Pineda, C. and Alfaro-Rodríguez, A. (2020) Nociceptive Related microRNAs and Their Role in Rheumatoid Arthritis. Molecular Biology Reports, 47, 7265-7272. https://doi.org/10.1007/s11033-020-05700-3
|
[69]
|
Tsuda, S., Sameshima, A., Sekine, M., Kawaguchi, H., Fujita, D., Makino, S., et al. (2020) Pre-Conception Status, Obstetric Outcome and Use of Medications during Pregnancy of Sys-temic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD) in Japan: Mul-ti-Center Retrospective Descriptive Study. Modern Rheumatology, 30, 852-861. https://doi.org/10.1080/14397595.2019.1661592
|
[70]
|
Qin, Y., Cai, M.L., Jin, H.Z., Huang, W., Zhu, C., Bozec, A., Huang, J. and Chen, Z. (2022) Age-Associated B Cells Contribute to the Pathogenesis of Rheumatoid Arthritis by In-ducing Activation of Fibroblast-Like Synoviocytes via TNF-α-Mediated ERK1/2 and JAK-STAT1 Pathways. Annals of the Rheumatic Diseases, 81, 1504-1514.
https://doi.org/10.1136/ard-2022-222605
|
[71]
|
Burmester, G.R. and Pope, J.E. (2017) Novel Treatment Strategies in Rheumatoid Arthritis. The Lancet, 389, 2338- 2348. https://doi.org/10.1016/S0140-6736(17)31491-5
|
[72]
|
Gravallese, E.M. and Firestein, G.S. (2023) Rheumatoid Ar-thritis—Common Origins, Divergent Mechanisms. The New England Journal of Medicine, 388, 529-542. https://doi.org/10.1056/NEJMra2103726
|
[73]
|
Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y. and Liang, C. (2021) Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Frontiers in Immunology, 12, Article ID: 686155. https://doi.org/10.3389/fimmu.2021.686155
|
[74]
|
Littlejohn, E.A. and Monrad, S.U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. Prim Care, 45, 237- 255. https://doi.org/10.1016/j.pop.2018.02.010
|
[75]
|
Bhamidipati, K. and Wei, K. (2022) Precision Medicine in Rheu-matoid Arthritis. Best Practice & Research: Clinical Rheumatology, 36, Article ID: 101742. https://doi.org/10.1016/j.berh.2022.101742
|